Page 1 of Clinical Trials for Biological adjuvanted A H1N1 influenza vaccine, 45 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Safety and Immune Response of Candidate H1N1 Influenza Vaccine GSK2340274A Following Seasonal Influenza Vaccination in Adults
Last Updated: August 11, 2011
Condition(s): Influenza
2
Active, not recruiting
Safety of and Immunogenicity to an H1N1 Influenza Vaccine in HIV-infected Adults
Last Updated: March 22, 2012
Condition(s): HIV Infection
3
Completed
A Study of Different Formulations of an Adjuvanted A/H1N1 Pandemic Vaccine in Healthy Adults and the Elderly
Last Updated: August 26, 2011
Condition(s): Influenza; Swine-origin A/H1N1 Influenza
4
Completed
Study to Evaluate Immunological Equivalence Between Two Investigational Influenza Vaccines in Adults (H1N1)
Last Updated: March 8, 2012
Condition(s): Influenza Infection
5
Completed
Rapid Evaluation of Pandemic H1N1 Influenza Vaccines in Young Children
Last Updated: February 9, 2010
Condition(s): H1N1/2009 Influenza
6
Terminated
H1N1sw Vaccine in Adult Transplant Recipients
Last Updated: April 13, 2012
Condition(s): Immunocompromised
7
Completed
Immunogenicity, Tolerability and Safety of One or Two Doses of an Adjuvanted Swine-origin A H1N1 Influenza Vaccine in Healthy Subjects 18 or More Years of Age Both Vaccinated and Not Yet Vaccinated Against Seasonal Influenza 2009/10
Last Updated: January 4, 2012
Condition(s): Pandemic Influenza Disease
8
Recruiting
Studies of Pandemic Influenza (H1N1) 2009 Vaccine in Bergen
Last Updated: October 27, 2009
Condition(s): Healthy
9
Completed
Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects 18 or More Years of Age
Last Updated: October 10, 2011
Condition(s): Pandemic Influenza
10
Completed
Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects 18 or More Years of Age
Last Updated: October 10, 2011
Condition(s): Pandemic Influenza
11
Completed
Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects From 6 Months to 17 Years of Age
Last Updated: October 7, 2011
Condition(s): Pandemic Influenza
12
Completed
Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine (Egg-Derived) in Healthy Subjects From 6 Months to 17 Years of Age
Last Updated: October 10, 2011
Condition(s): Pandemic Influenza
13
Completed
A Study to Evaluate the Safety and Immunogenicity of an Inactivated Split-virion Influenza A(H1N1) Vaccine
Last Updated: September 17, 2010
Condition(s): Influenza Infection
14
Active, not recruiting
Clinical Trial to Compare the Immunogenicity, Safety, and Tolerability of an Adjuvanted A(H1N1) Influenza Vaccine Versus Non-Adjuvanted A(H1N1) Influenza Vaccines in Patients With Invasive Solid Tumors
Last Updated: February 6, 2012
Condition(s): H1N1 Influenza Virus; Invasive Solid Tumors
15
Active, not recruiting
Clinical Trial to Compare the Immunogenicity, Safety, and Tolerability of an Adjuvanted A(H1N1) Influenza Vaccine Versus Non-Adjuvanted A(H1N1) Influenza Vaccines in Patients With HIV-1 Infection
Last Updated: February 6, 2012
Condition(s): H1N1 Influenza Virus; Human Immunodeficiency Virus Type 1 (HIV-1) Infection
16
Active, not recruiting
Clinical Trial to Compare the Immunogenicity, Safety, and Tolerability of an Adjuvanted A(H1N1) Influenza Vaccine Versus Non-Adjuvanted A(H1N1) Influenza Vaccines in Patients With Chronic Pulmonary Disease, Chronic Heart Disease, or Diabetes Mellitus
Last Updated: February 6, 2012
Condition(s): H1N1 Influenza Virus; Chronic Pulmonary Disease; Chronic Heart Disease; Diabetes Mellitus
17
Completed
Clinical Study to Evaluate Antibody and Cell Mediated Immunity of A/H1N1 Influenza Vaccine in Healthy Subjects
Last Updated: May 2, 2012
Condition(s): Influenza
18
Completed
Single-blind, Dose-ranging Study of Novel Swine Influenza Virus Vaccine in Japanese Pediatric Subjects
Last Updated: January 4, 2012
Condition(s): Swine-Origin Influenza A H1N1 Virus
19
Completed
Single-blind, Dose-ranging Study of Novel Swine Influenza Virus Vaccine in Japanese Adult Subjects
Last Updated: September 13, 2011
Condition(s): Influenza
20
Completed
Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children, Adolescents and Adults (3 to 64 Years)
Last Updated: April 22, 2011
Condition(s): Novel 2009 Influenza H1N1

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Biological+adjuvanted+A+H1N1+influenza+vaccine

Page 1 of Clinical Trials for Biological adjuvanted A H1N1 influenza vaccine, 45 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About